Indivior Pharmaceuticals, Inc.

INDV

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001625297

SEC filings (opens in a new tab)

In the last 90 days, Indivior Pharmaceuticals, Inc. insiders filed 2 open-market purchases and 1 sale; 337 institutions reported holding it in 13F filings for Q2 2026, worth $4.98B in total; Oaktree Capital is the only superinvestor holding it.

Q3 2024 vs. Q2 2024

How the institutions holding Indivior Pharmaceuticals, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024 All holders in Q2 2024

13F holders of INDV: Q2 2024 compared with Q3 2024
Measure	Q2 2024	Of which not filed for Q3 2024	Q3 2024	Change
Holders	99	1	103	+5
Shares	64.8M	150	73.0M	+8.24M (+12.7%)
Value	$1.03B	$2.42K	$720.7M	−$307.9M (−29.9%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (27)

Institutions that held Indivior Pharmaceuticals, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to INDV in Q3 2024
Institution	Shares	Value	% of portfolio
Deerfield Management Company, L.P. (Series C)	5,092,642	$49.7M	0.74%
Mangrove Partners	1,156,010	$11.3M	1.09%
Newtyn Management, LLC	868,105	$8.46M	1.30%
Iron Triangle Partners LP	845,470	$8.24M	1.16%
Krensavage Asset Management, LLC	701,873	$6.84M	3.83%
VR Advisory Services Ltd	641,210	$6.32M	2.18%
CenterBook Partners LP	558,683	$5.45M	0.33%
Fund 1 Investments, LLC	550,403	$5.37M	0.84%
Rokos Capital Management LLP	500,032	$4.88M	0.17%
Stonepine Capital Management, LLC	270,000	$2.63M	1.66%
Clark Estates Inc	254,100	$2.48M	0.46%
AlphaCentric Advisors LLC	242,500	$2.36M	1.76%
Trexquant Investment LP	171,414	$1.67M	0.02%
Petrus Trust Company, LTA	128,277	$1.25M	0.12%
Mediolanum International Funds Ltd	124,624	$1.24M	0.02%
Voloridge Investment Management, LLC	63,521	$619.3K	0.00%
Valence8 US LP	57,293	$564.2K	0.25%
PDT Partners, LLC	54,924	$535.5K	0.05%
Aster Capital Management (DIFC) Ltd	52,662	$513.5K	0.11%
Verition Fund Management LLC	38,434	$374.7K	0.00%
Engineers Gate Manager LP	32,861	$320.4K	0.01%
Public Employees Retirement System of Ohio	29,794	$294.3K	0.00%
Jane Street Group, LLC	18,270	$180.0K	0.00%
Graham Capital Management, L.P.	14,169	$138.1K	0.00%
Melqart Asset Management (UK) Ltd	13,510	$131.7K	0.01%
Man Group plc	11,594	$113.0K	0.00%
Stifel Financial Corp	10,225	$99.7K	0.00%

Sold out (22)

Institutions that held Indivior Pharmaceuticals, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of INDV in Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
Toronto Dominion Bank	1,141,377	$18.4M
Premier Fund Managers Ltd	871,133	$13.9M
Mackenzie Financial Corp	497,555	$7.80M
Exor Capital LLP	474,000	$7.43M
Acadian Asset Management LLC	277,197	$4.34M
Corbin Capital Partners, L.P.	199,574	$3.38M
Arrowstreet Capital, Limited Partnership	179,497	$2.83M
Renaissance Group LLC	130,529	$2.10M
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main	126,542	$1.98M
Torno Capital, LLC	70,500	$1.14M
Campbell & CO Investment Adviser LLC	63,521	$995.5K
Envestnet Asset Management Inc	41,695	$672.1K
Royal London Asset Management Ltd	35,416	$570.9K
Cubist Systematic Strategies, LLC	25,236	$406.8K
Y-Intercept (Hong Kong) Ltd	20,022	$322.8K
Schonfeld Strategic Advisors LLC	17,398	$280.5K
Bank of New York Mellon Corp	11,672	$188.2K
Jump Financial, LLC	11,098	$178.9K
LMR Partners LLP	10,489	$169.1K
Lazard Asset Management LLC	5,505	$88.0K
Russell Investments Group, Ltd.	2,210	$34.6K
Forsta Ap-Fonden	29,908	$0

Not filed for Q3 2024 yet (1)

Institutions that held Indivior Pharmaceuticals, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding INDV in Q2 2024 that haven't filed for Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
ICA Group Wealth Management, LLC	150	$2.42K